An escalating dose/multiple high-dose binge pattern of amphetamine administration results in differential changes in the extracellular dopamine response profiles in caudate-putamen and nucleus accumbens

Journal of Neuroscience

Volumn 17, Issue 11, 1997, Pages 4441-4447

  Kuczenski, Ronald ^a   Segal, David S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

amphetamine; binge; caudete putamen; dopamine; locomotion; microdialysis; nucleus accumbens; psychosis; stereotypy

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; AMPHETAMINE; DOPAMINE; HOMOVANILLIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG ABUSE; LIMBIC SYSTEM; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PSYCHOSIS; PUTAMEN; RAT; STEREOTYPY; SUBCUTANEOUS DRUG ADMINISTRATION; TACHYPHYLAXIS;

EID: 0030917606     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.17-11-04441.1997     Document Type: Article

References (48)

1. Angrist B (1987) Clinical effects of central nervous system stimulants: a selective update. In: Brain reward systems and abuse (Engel J, Oreland L, eds), pp 109-127. New York: Raven.
2. Angrist B (1994a) Amphetamine psychosis: clinical variations of the syndrome. In: Amphetamine and its analogues (Cho AK, Segal DS, eds), pp 387-414. San Diego: Academic.
3. Angrist B (1994b) Psychosis-inducing effects of cocaine may show sensitization more than other effects. Neuropsychopharmacol 10:197S.
4. Axt KJ, Mamounas LA, Molliver ME (1994) Structural features of amphetamine neurotoxicity. In: Amphetamine and its analogs (Cho AK, Segal DS, eds), pp 315-367. San Diego: Academic.
5. Benet LZ, Mitchell JR, Sheiner LB (1990) Pharmacokinetics: the dynamics of drug absorption, distribution, and elimination. In: Goodman and Oilman's the pharmacological basis of therapeutics (Gilman AG, Rall TW, Nies AS, Taylor P, eds), pp 3-32. New York: Pergamon.
6. Benveniste H, Hansen AJ, Ottosen NS (1989) Determination of brain interstitial concentrations by microdialysis. J Neurochem 52:1741-1750.
7. Bowyer JF, Holson RR (1995) Methamphetamine and amphetamine neurotoxicity. In: Handbook of neurotoxicology (Chang LW, Dyer RS, eds), pp 845-870. New York: Marcel Dekker.
8. Bowyer JF, Tank AW, Newport GD, Slikker Jr W, Ali SF, Holson RR (1992) The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels in rat striatum. J Pharmacol Exp Ther 260:817-824.
9. Bowyer JF, Gough B, Slikker Jr W, Lipe GW, Newport GD, Holson RR (1993) Effects of a cold environment or age on methamphetamineinduced dopamine release in the caudate putamen of female rats. Pharmacol Biochem Behav 44:87-98.
10. Butcher SP, Fairbrother IS, Kelly JS, Arbuthnott GW (1988) Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study. J Neurochem 50:346-355.
11. Cadoni C, Pinna A, Russi G, Consolo S, Di Chiara G (1995) Role of vesicular dopamine in the in vivo stimulation of striatal dopamine transmission by amphetamine: evidence from microdialysis and Fos immunohistochemistry. Neuroscience 65:1027-1039.
12. Castañeda E, Whishaw IQ, Lermer L, Robinson TE (1990) Dopamine depletion in neonatal rats: effects on behavior and striatal dopamine release assessed by intracerebral microdialysis during adulthood. Brain Res 508:30-39.
13. Church WH, Justice Jr JB (1987) Rapid sampling and determination of extracellular dopamine. Anal Chem 59:712-716.
14. Clausing P, Gough B, Holson RR, Slikker Jr W, Bowyer JF (1995) Amphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects. J Pharmacol Exp Ther 274:614-621.
15. Costall B, Naylor RJ (1977) Mesolimbic and extrapyramidal sites for the mediation of stereotyped behavior patterns and hyperactivity by amphetamine and apomorphine in the rat. In: Cocaine and other stimulants (Ellinwood EH, Kilbey MM, eds), pp 47-76. New York: Plenum.
16. Davis JM, Schlemmer Jr FP (1980) The amphetamine psychosis. In: Amphetamines and related stimulants: chemical, biological, clinical and social aspects (Caldwell J, ed), pp 161-173. Boca Raton, FL: CRC.
17. Ellison G, Eison MS (1983) Continuous intoxication: an animal model of the acute psychotic episode. Psychol Med 13:751-761.
18. Ellison G, Eison MS, Huberman HS, Daniel F (1978) Long-term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration. Science 276-278.
19. Fischman MW, Schuster CR (1974) Tolerance development to chronic methamphetamine intoxication in the rhesus monkey. Pharmacol Biochem Behav 2:503-508.
20. Fischman MW, Schuster CR (1977) Long-term behavioral changes in the rhesus monkey after multiple daily injections of D-methylamphetamine. J Pharmacol Exp Ther 201:593-605.
21. Gawin FH (1991) Cocaine addiction: psychology and neurophysiology. Science 251:1580-1586.
22. Gawin FH, Khalsa ME (1996) Sensitization and "street" stimulant addiction. In: Neurotoxicity and neuropathology associated with stimulant abuse. NIDA Research Monograph Series (Majewska MD, ed), pp 224-250. Washington, DC: U.S. Government Printing Office.
23. Gibb JW, Hanson GR, Johnson M (1994) Neurochemical mechanisms of toxicity. In: Amphetamine and its analogs (Cho AK, Segal DS, eds), pp 269-295. San Diego: Academic.
24. Henry DJ, Greene MA, White FJ (1989) Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: repeated administration. J Pharmacol Exp Ther 251:833-839.
25. Kalivas PW, Alesdatter JE (1993) Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral Sensitization to cocaine. J Pharmacol Exp Ther 267:486-495.
26. Kamata K, Rebec GV (1984) Long-term amphetamine treatment attenuates or reverses the depression of neuronal activity produced by dopamine agonists in the ventral tegmental area. Life Sci 34:2419-2427.
27. Karler R, Calder LD, Chaudhry IA, Turkanis SA (1989) Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. Life Sci 45:599-606.
28. Kelly P, Iversen SD (1976) Selective 60HDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activities in rats. Eur J Pharmacol 40:45-56.
29. Kuczenski R (1977a) Biphasic effects of amphetamine on striatal dopamine dynamics. Eur J Pharmacol 46:249-257.
30. Kuczenski R (1977b) Differential effects of reserpine and tetrabenazine on rat striatal synaptosomal dopamine biosynthesis and synaptosomal dopamine pools. J Pharmacol Exp Ther 201:357-367.
31. Kuczenski R (1979) Effects of para-chlorophenylalanine on amphetamine and haloperidol-induced changes in striatal dopamine turnover. Brain Res 164:217-225.
32. Kuczenski R, Segal DS (1989) Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J Neurosci 9:2051-2065.
33. Nash JF, Yamamoto BK (1992) Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine. Brain Res 581:237-243.
34. Paulson PE, Robinson TE (1995) Amphetamine-induced timedependent Sensitization of dopamine neurotransmission in the dorsal and ventral striatum: a microdialysis study in behaving rats. Synapse 19:56-65.
35. Pitts DK, Kelland MD, Freeman AS, Chiodo LA (1993) Repeated amphetamine administration: role of forebrain in reduced responsiveness of nigrostriatal dopamine neurons to dopamine agonists. J Pharmacol Exp Ther 264:616-621.
36. Roberts DCS, Zis AP, Fibiger H (1975) Ascending catecholamine pathways and amphetamine induced locomotion: importance of dopamine and apparent noninvolvement of norepinephrine. Brain Res 93:441-454.
37. Robinson TE, Whishaw IQ (1988) Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats. Brain Res 450:209-224.
38. Schmidt CJ, Gehlert DR, Peat MA, Sonsalla PK, Hanson GR, Wamsley JK, Gibb JW (1985a) Studies on the mechanism of tolerance to methamphetamine. Brain Res 343:305-313.
39. Schmidt CJ, Sonsalla PK, Hanson GR, Peat MA, Gibb JW (1985b) Methamphetamine-induced depression of monoamine synthesis in the rat: development of tolerance. J Neurochem 44:852-855.
40. Swerdlow NR, Hauger R, Irwin M, Koob GF, Britton KT, Pulvirenti L (1991) Endocrine, immune, and neurochemical changes in rats during withdrawal from chronic amphetamine intoxication. Neuropsychopharmacology 5:23-31.
41. Tyler CB, Galloway MP (1992) Acute administration of amphetamine: differential regulation of dopamine synthesis in dopamine projection fields. J Pharmacol Exp Ther 261:567-573.
42. Wages SA, Church WH, Justice Jr JB (1986) Sampling considerations for on-line microbore liquid chromatography of brain dialysis. Anal Biochem 58:1649-1656.
43. Weihmuller FB, O'Dell SJ, Marshall JF (1992) MK-801 protection against methamphetamine-induced striatal dopamine terminal injury is associated with attenuated dopamine overflow. Synapse 11:155-163.
44. White FJ, Wang RY (1984) Electrophysiological evidence for A10 dopamine autoreceptor subsensitivity following chronic D-amphetamine treatment. Brain Res 309:283-292.
45. White FJ, Hu X-T, Zhang X-F, Wolf ME (1995) Repeated administration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system. J Pharmacol Exp Ther 273:445-454.
46. Wolf ME, Khansa MR (1991) Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine. Brain Res 562:164-168.
47. Wolf ME, White FJ, Hu X-T (1994) MK-801 Prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine. J Neurosci 14:1735-1745.
48. Zhang Y, Angulo JA (1996) Contrasting effects of repeated treatment vs withdrawal of methamphetamine on tyrosine hydroxylase messenger RNA levels in the ventral tegmental area and substantia nigra zona compacta of the rat brain. Synapse 24:218-223.